Imunon Inc
For the period ended Dec 31, 2023. Filed Mar 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 28, 2024
IMNN$0.88+4.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Loss
| Years Ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Other comprehensive loss | ||
| Changes in: | ||
| Realized gains on investment securities recognized in investment income, net | 431,801 | 49,222 |
| Unrealized losses on investment securities, net | (397,499) | (14,754) |
| Change in realized and unrealized gains on available for sale securities, net | 34,302 | 34,468 |
| Net loss | (19,514,977) | (35,898,234) |
| Total comprehensive loss | $(19,480,675) | $(35,863,766) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.